A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Brensocatib in Participants with Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) – The BiRCh Study

Journal of Allergy and Clinical Immunology 2026

View at publisher
Authors: Philippe Gevaert, Randall A. Ow, Jorge Maspero, Claus Bachert, Seong Cho, Wytske Johanna Fokkens, Ariel A. Teper, Carlos Fernandez, Kevin C. Mange, Irene Gregan, Zhiying Qiu, Joseph K. Han
DOI: 10.1016/j.jaci.2025.12.264
Cited by: 0

Fields of Study & Subjects

Sinusitis and nasal conditions Cystic Fibrosis Research Advances Antifungal resistance and susceptibility

Publication details

Journal / source
Journal of Allergy and Clinical Immunology
Volume
157
Issue
2
Pages
AB89–AB89
Publication date
1 February 2026
Language
EN